Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

Clinical trial NCT04293679 · COMPLETED

Trial details

NCT number: NCT04293679
Sponsor: Sirnaomics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bowen's Disease Cutaneous Squamous Cell Carcinoma in Situ

Start date: 2019-03-21
Primary completion: 2020-10-21
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.